1
|
Khairnar P, Saathoff JM, Cook DW, Hochstetler SR, Pandya U, Robinson SJ, Satam V, Donsbach KO, Gupton BF, Jin LM, Shanahan CS. Practical Synthesis of 6-Amino-1-hydroxy-2,1-benzoxaborolane: A Key Intermediate of DNDI-6148. Org Process Res Dev 2024; 28:1213-1223. [PMID: 38660377 PMCID: PMC11036395 DOI: 10.1021/acs.oprd.4c00031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2024] [Revised: 03/03/2024] [Accepted: 03/11/2024] [Indexed: 04/26/2024]
Abstract
Visceral leishmaniasis (VL), a parasitic, poverty-linked, neglected disease, is endemic across multiple regions of the world and fatal if untreated. There is an urgent need for a better and more affordable treatment for VL. DNDI-6148 is a promising drug candidate being evaluated for the treatment of VL; however, the current process for producing the key intermediate of DNDI-6148, 6-amino-1-hydroxy-2,1-benzoxaborolane, is expensive and difficult to scale up. Herein, we describe two practical approaches to synthesizing 6-amino-1-hydroxy-2,1-benzoxaborolane from inexpensive and readily available raw materials. Starting with 4-tolunitrile, the first approach is a five-step sequence involving a Hofmann rearrangement, resulting in an overall yield of 40%. The second approach utilizes 2-methyl-5-nitroaniline as the starting material and features borylation of aniline and continuous flow hydrogenation as the key steps, with an overall yield of 46%. Both routes bypass the nitration of 1-hydroxy-2,1-benzoxaborolane, which is challenging and expensive to scale. In particular, the second approach is more practical and scalable because of the mild operating conditions and facile isolation process.
Collapse
Affiliation(s)
- Pankaj
V. Khairnar
- Medicines
for All Institute, Virginia Commonwealth
University, Richmond, Virginia 23284-3068, United States
| | - John M. Saathoff
- Medicines
for All Institute, Virginia Commonwealth
University, Richmond, Virginia 23284-3068, United States
| | - Daniel W. Cook
- Medicines
for All Institute, Virginia Commonwealth
University, Richmond, Virginia 23284-3068, United States
| | - Samuel R. Hochstetler
- Medicines
for All Institute, Virginia Commonwealth
University, Richmond, Virginia 23284-3068, United States
| | - Urvish Pandya
- Drugs
for Neglected Diseases initiative, 15 Chemin Camille-Vidart, 1202 Geneva, Switzerland
| | - Stephen J. Robinson
- Drugs
for Neglected Diseases initiative, 15 Chemin Camille-Vidart, 1202 Geneva, Switzerland
| | - Vijay Satam
- Drugs
for Neglected Diseases initiative, 15 Chemin Camille-Vidart, 1202 Geneva, Switzerland
| | - Kai O. Donsbach
- Medicines
for All Institute, Virginia Commonwealth
University, Richmond, Virginia 23284-3068, United States
| | - B. Frank Gupton
- Medicines
for All Institute, Virginia Commonwealth
University, Richmond, Virginia 23284-3068, United States
| | - Li-Mei Jin
- Medicines
for All Institute, Virginia Commonwealth
University, Richmond, Virginia 23284-3068, United States
| | - Charles S. Shanahan
- Medicines
for All Institute, Virginia Commonwealth
University, Richmond, Virginia 23284-3068, United States
| |
Collapse
|
2
|
Dhawan B, Akhter G, Hamid H, Kesharwani P, Alam MS. Benzoxaboroles: New emerging and versatile scaffold with a plethora of pharmacological activities. J Mol Struct 2022. [DOI: 10.1016/j.molstruc.2021.132057] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
3
|
Grygorenko OO, Volochnyuk DM, Vashchenko BV. Emerging Building Blocks for Medicinal Chemistry: Recent Synthetic Advances. European J Org Chem 2021. [DOI: 10.1002/ejoc.202100857] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Oleksandr O. Grygorenko
- Enamine Ltd. Chervonotkatska 78 Kyiv 02094 Ukraine
- Taras Shevchenko National University of Kyiv Volodymyrska Street 60 Kyiv 01601 Ukraine
| | - Dmitriy M. Volochnyuk
- Enamine Ltd. Chervonotkatska 78 Kyiv 02094 Ukraine
- Taras Shevchenko National University of Kyiv Volodymyrska Street 60 Kyiv 01601 Ukraine
- Institute of Organic Chemistry National Academy of Sciences of Ukraine Murmanska Street 5 Kyiv 02094 Ukraine
| | - Bohdan V. Vashchenko
- Enamine Ltd. Chervonotkatska 78 Kyiv 02094 Ukraine
- Taras Shevchenko National University of Kyiv Volodymyrska Street 60 Kyiv 01601 Ukraine
| |
Collapse
|
5
|
Singh A, Kumar R. Sustainable Passerini-tetrazole three component reaction (PT-3CR): selective synthesis of oxaborol-tetrazoles. Chem Commun (Camb) 2021; 57:9708-9711. [PMID: 34555131 DOI: 10.1039/d1cc03256a] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
A sustainable catalyst- and solvent-free Passerini-tetrazole three component reaction (PT-3CR) has been developed for the selective synthesis of benzoxaborol-tetrazoles for the first time. The synthetic potential of oxaboroles was demonstrated towards various functionalized tetrazoles, which are otherwise difficult to achieve through conventional PT-3CR from aromatic aldehydes/ketones. The reaction features high practicality, broad substrate scope and excellent yields (80-98%). Preliminary results of the asymmetric PT-3CR are also shown for the synthesis of chiral benzoxaboroles.
Collapse
Affiliation(s)
- Akansha Singh
- Division of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Lucknow-226031, India. .,Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, UP-201002, India
| | - Ravindra Kumar
- Division of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Lucknow-226031, India. .,Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, UP-201002, India
| |
Collapse
|